Pharma BD Deal Intelligence

GlaxoSmithKline plc / Genelabs Technologies, Inc.

2008 · Acquisition/Merger · $57M · Complete

Announcement Sentiment
75
Strongly positive

$1.30/share tender; Hepatitis C novel small molecule programs; tender completed Jan 2009

Key facts

See the full interactive analysis, sources & comparables →